ODDB.org: Open Drug Database

Lipomed AG - Xaluprine 20 mg/ml, Suspension zum Einnehmen

Swissmedic Registration	65371	Sequence	01
Product name	Xaluprine 20 mg/ml	Description	Suspension zum Einnehmen
ATC-Classification	L01BB02	ATC-Description	Mercaptopurine
Introduction of Sequence	18.12.2014

Composition

mercaptopurinum monohydricum 20 mg, xanthani gummi, aspartamum 3 mg, rubi idaei succus concentratus cum saccharum max. 32 mg et E 220 max. 0.24 mg, E 219 1.15 mg, E 215 0.57 mg, E 202, natrii hydroxidum, aqua purificata ad suspensionem pro 1 ml corresp. natrium max. 0.68 mg.

Packungsbestandteile

Galenic Form

Suspension (oral)

Excipiens

Active Agent	Dose
Mercaptopurinum Monohydricum	20 mg/ml

Inactive agents	Dose	additional_information
Aspartame	3 mg/ml
E 202		conserv.
E 215	0.57 mg/ml	conserv.
E 219	1.15 mg/ml	conserv.
Sodium Hydroxide
Rubi Idaei Succus Concentratus cum Saccharum	32 mg/ml
Xanthani Gummi

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	100 ml	PR	PR	A		Yes

2024	©ywesee GmbH